Profile setting for Default Landing Page
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech :- Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine :- Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech :- Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business :- Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News

    Total record(s) 1620 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>

    iDD biotech Enters Worldwide Exclusive Licence Concerning Antibodies and Patents Related to CK8 - Yahoo Finance

      iDD biotech has announced earlier today the signature of an exclusive worldwide licence with PULSALYS, the Technology Transfer Office of Lyon University, to scale-up and accelerate the develo Save |  Share  Email 30th Mar 2017 

    FDA approves Roche's Ocrevus for relapsing and primary progressive MS - Pharmaceutical Business Review

      Pharmaceutical Business Review Roche has secured approval from the US Food and Drug Administration (FDA) for its Ocrevus (ocrelizumab) to treat patients with relapsing and primary progressive forms Save |  Share  Email 30th Mar 2017 

    Germline Genetic Biomarkers of Sunitinib Efficacy in Advanced Renal Cell Carcinoma: Results From the RENAL ... - UroToday

      Informed consent for pharmacogenetics research was obtained from 202 out of 289 treated patients in the trial. Associations between 9 SNP variants (CXCL8, LOXL2, CCDC26, SH3GL2, CLL Save |  Share  Email 30th Mar 2017 

    FIT Biotech Oy: Appointment to FIT Biotech's Management Team - Yahoo Finance

      The Board of Directors of the Finnish biotechnology company FIT Biotech Oy ("Company") today announced the appointment of Santeri Kiviluoto, PhD, as the Company`s new Chief Scientific Officer. He will assume his Save |  Share  Email 29th Mar 2017 

    Arizona youth joins tribal officials to push for diabetes program funds - Cronkite News

      Cronkite News Alton Villegas, 11, a member of the Salt River Pima-Maricopa Indian Community, which is plagued by diabetes. He charmed a Senate committee with his own story at a hearing on saving tribal diabetes fundi Save |  Share  Email 29th Mar 2017 

    Morgan Stanley Reiterates "Overweight? Rating for China Biologic ... - Chaffey Breeze

      Morgan Stanley reiterated their overweight rating on shares of China Biologic Products Inc (NASDAQ:CBPO) in a research note published on Friday morning.Is China Biologic Products, Inc. (NASDAQ:CBPO) a Stock To Hold Save |  Share  Email 29th Mar 2017 

    Promentis Pharmaceuticals raises $26 million - Milwaukee Journal Sentinel

      Milwaukee Journal Sentinel Promentis Pharmaceuticals Inc., a Milwaukee company that is developing drugs to treat schizophrenia and other psychiatric disorders, has raised an additional $17.2 million from investors, bringing the to Save |  Share  Email 29th Mar 2017 

    Low-cost diabetes prevention program coming to Tahoe Forest Health System - Sierra Sun

      Radio Iowa Often times, doctors like to "watch" patients who have risk factors for diabetes, including being overweight and having slightly elevated blood sugars, because there hasn't been a place for th Save |  Share  Email 29th Mar 2017 

    Dave & Buster's declines while Vertex Pharmaceuticals jumps - ABC News

      The maker of communications analysis software disclosed solid earnings and discussed the idea of splitting into two companies. Dave & Buster's Entertainment Inc., down $2.10 to $60.09. The arcade and restaurant chain Save |  Share  Email 29th Mar 2017 

    San Carlos Center Educating Community on Diabetes - KRGV

      KRGV SAN CARLOS - With thousands of people suffering from diabetes in the Rio Grande Valley, one community works to keep themselves educated and fight against it. The San Carlos Community Resource Center prides itself on helping its community with Save |  Share  Email 29th Mar 2017 

    Type 2 diabetes not real illness says top doctor Muir Gray - Daily Mail

      Daily Mail Type 2 diabetes should be renamed 'walking deficiency syndrome' because it is not a 'real disease', according to one of Britain's leading medical practitioners. Sir Muir Gray has done extensive researc Save |  Share  Email 29th Mar 2017 

    Top Biotech Stocks for Growth Investors - Motley Fool

      Motley Fool Cory Renauer (Omeros Corporation): Sales of this biotech's pupil-dilating solution are growing so fast, I could hardly believe my eyes when I saw its latest earnings report. Last year Omidria sales jumped 212% higher than 2 Save |  Share  Email 29th Mar 2017 

    VBI Vaccines Emerges as Strong Biotech Stock - Few industries can yield gains that are as explosive and as quick-moving as the biotech industry. And even though the ongoing healthcare debacle in Washington has given this corner of the market some thrills and chills in recent Save |  Share  Email 29th Mar 2017 

    Biotech Forum Daily Digest: Behind Vertex's Big Rally. Spotlight On Lion Biotechnology - Seeking Alpha

      Seeking Alpha The biotech sector and the overall market are doing better than expected after a major legislative effort failed in the House last week. Robust consumer confidence levels are helping Save |  Share  Email 29th Mar 2017 

    US senator launches opioid drugmaker probe - PharmaLive (press release) (subscription)

      U.S. Democratic Senator Claire McCaskill sought on Tuesday details from the nation's top opioid drugmakers on their sales and marketing practices, as lawmakers step up efforts to tackle the country' Save |  Share  Email 29th Mar 2017 

    US approves Roche drug for severe form of MS - PharmaLive (press release) (subscription) Roche's multiple sclerosis (MS) drug Ocrevus won U.S. approval, putting the potential blockbuster back on track after a brief delay and giving a lift to patients with a form of the disease that until Save |  Share  Email 29th Mar 2017 

    Vertex CF combo succeeds in late-stage trials - PharmaLive (press release) (subscription)

      Vertex Pharmaceuticals Inc said on Tuesday its Kalydeco cystic fibrosis treatment given with an experimental drug demonstrated significant improvements in lung function in a pair of late-stage trials the company p Save |  Share  Email 29th Mar 2017 

    Vertex Pharmaceuticals Reaches Upside Price Target -

      We last discussed Vertex Pharmaceuticals (VRTX) on Nov. 29 and we looked for more base building to continue, which it did until this morning when prices gapped to the upside. VRTX jumped over $20 in heavy volume and only a few days afte Save |  Share  Email 29th Mar 2017 

    Bill Ackman Finally Apologizes for His 'Huge Mistake' With Valeant - Fortune

      Fortune After calling it quits on his investment in Valeant Pharmaceuticals earlier this month, Bill Ackman is taking full responsibility for his choices which ultimately led to a $4 billion disaster for his hedge fund Save |  Share  Email 29th Mar 2017 

    Putting Safety at the Center of Clinical Studies - Applied Clinical Trials Online (press release) (registration) (blog)

      A medicine gets developed with the objective of improved benefit for a patient population with common characteristics, which are typically determined by pharmacogenetics. Pharmacogene Save |  Share  Email 29th Mar 2017 
    Total record(s) 1620 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
    Profile setting for Default Landing Page